22 results
8-K
EX-10.1
IMPLQ
Impel Pharmaceuticals Inc
20 Dec 23
Impel Pharmaceuticals Announces Filing Voluntary Chapter 11 Cases and Signing of “Stalking Horse” Agreement to Facilitate Sale
6:08am
as disclosed on Schedule 3.11(b), to the Knowledge of the Seller, no supplier has or has threatened to stop or decrease the rate of, or as a result … , borrower, creditor, guarantor, business partner, bank, landlord, tenant, supplier, customer, employee, manager, franchisee, distributer, noteholder
10-K/A
2022 FY
EX-3.2
IMPLQ
Impel Pharmaceuticals Inc
31 Mar 23
Annual report (amended)
4:21pm
by the Corporation or its affiliates) of the Corporation or significant supplier or customer of the Corporation, within the three (3) years preceding
10-K
xpk6 m5wua4d
29 Mar 22
Annual report
5:09pm
424B4
2b1c3o8i4femfs 50agl
10 Sep 21
Prospectus supplement with pricing info
4:01pm
DRS
fyskw73jn7ksb98fgpy
25 Aug 21
Draft registration statement
12:00am
10-Q
jpbf16ve 1uscv1626
7 Jun 21
Quarterly report
7:17am
10-Q
EX-3.2
a9v29cisbc0bc
7 Jun 21
Quarterly report
7:17am
424B1
zox2puhzc
23 Apr 21
Prospectus with pricing info
4:01pm
S-1
EX-10.9
g13dv8r1fwz1uttp
2 Apr 21
IPO registration
3:04pm